TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Interestingly, it suggested a strong link between the TM6SF2 E167K variant and the risk of NAFLD in a dominant model (CT + TT, OR = 2.327, 95% CI: 1.542–3.513, P = 0.000).